Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Cancer J. 2016 Sep-Oct;22(5):330–333. doi: 10.1097/PPO.0000000000000216

Table 1.

Early phase clinical trial experience with testosterone-based therapies.44, 49, 51

Author Accrual Median Age Median PSA (ng/mL) at Enrollment % Achieving PSA Decrease Time to Progression (Days) Etoposide included?
Szmulewitz et al. 15 73 11.1 20 63(14–672) No etoposide
Morris et al. 12 65 9.1 58 86 (27–250) No etoposide
Schweizer et al. 14 71 21.7 50 221 (95 – 454) Etoposide included